Pectoreal
Pectoreal is developing tissue-engineered natural breast implants designed for single-procedure implantation at the time of mastectomy or lumpectomy. The company's Pectofil and Pectograft implants are reverse-engineered from natural breast tissue to be minimally immunogenic, integrating with blood supply and sensation while reducing complications and hospital stays. The technology is also extendable to other reconstructive and aesthetic procedures including breast augmentation, rhinoplasty, and facelifts.
- Medical Devices
- Biotechnology
- Healthcare Technology
- New Materials
- Hardware
Funding
Founders
Founder details are not available yet.
Product
Problem
Current breast reconstruction options after mastectomy—autologous tissue flaps or synthetic implants—carry substantial drawbacks. Synthetic implants have high failure rates and have been subject to recalls, while autologous reconstruction requires multiple surgeries and long hospital stays, causing complications and psychological trauma for cancer survivors.
Solution
Pectoreal is developing two classes of natural breast implants, Pectofil and Pectograft, designed for single-procedure implantation at the time of primary mastectomy or lumpectomy. The implants are engineered from reverse-engineered natural breast tissue that is minimally immunogenic, allowing the material to integrate naturally with blood supply and sensation. This reduces the risk of complications, eliminates the need for repeat operations, and shortens hospitalisation time. The technology aims to restore both cosmesis and sensation, which are vital for the psychological and social wellbeing of patients.
Target Audience
Primary users are breast cancer survivors undergoing mastectomy or lumpectomy, as well as cosmetic patients seeking breast augmentation. The products are designed for plastic surgeons and reconstructive surgeons who need safer, more natural implant options.
Features
- Reverse-engineered adipose tissue technology that promotes regeneration of natural breast tissue post-implantation
- Two product classes designed specifically for lumpectomy and radical mastectomy clinical presentations
- Minimally immunogenic, off-the-shelf products that integrate naturally with blood supply and sensation
- Single-operation implantation concurrent with primary surgery, reducing surgical complications and hospital days
- Technology extendable to other reconstructive and aesthetic procedures including breast augmentation, rhinoplasty, facelift, thigh lift, buttock lift, and vaginal reconstruction